Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Minimum Effective Dose”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Not applicableStudy completedNCT00002394
What this trial is testing

Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment

Who this might be right for
Candidiasis, OralHIV Infections
Novartis 30
Large-scale testing (Phase 3)Ended earlyNCT03711162
What this trial is testing

A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care

Who this might be right for
Idiopathic Pulmonary Fibrosis
Galapagos NV 525
Not applicableStudy completedNCT00716755
What this trial is testing

Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Centre for Addiction and Mental Health 45
Testing effectiveness (Phase 2)Study completedNCT00379613
What this trial is testing

Use of Sugammadex Administered at 5 Minutes After Administration of 1.2 mg/kg Esmeron® (19.4.205)(P05942)

Who this might be right for
Anesthesia, General
Merck Sharp & Dohme LLC 45
Early research (Phase 1)Ended earlyNCT04748848
What this trial is testing

A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy

Who this might be right for
Leukemia, Myeloid
Celgene 1
Large-scale testing (Phase 3)Study completedNCT00261599
What this trial is testing

An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy

Who this might be right for
Conscious Sedation
Eisai Inc. 300
Not applicableUnknownNCT04705974
What this trial is testing

MED90 of Ropivacaine for Peripheral Nerve Block on Posture-evoked Pain in Spinal Anesthesia Positioning

Who this might be right for
Hip Fractures
Huazhong University of Science and Technology 180
Testing effectiveness (Phase 2)Study completedNCT02036970
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionInterstitial Lung Disease+9 more
Biogen 166
Post-approval studies (Phase 4)Study completedNCT00904709
What this trial is testing

The Assessment of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding Disorders

Who this might be right for
Menorrhagia
K. Sue Robinson 249
Large-scale testing (Phase 3)Study completedNCT03512197
What this trial is testing

A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
Novartis Pharmaceuticals 511
Testing effectiveness (Phase 2)UnknownNCT00311337
What this trial is testing

VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT)

Who this might be right for
Multiple Myeloma
University of Wuerzburg 61
Testing effectiveness (Phase 2)Looking for participantsNCT06852963
What this trial is testing

A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001

Who this might be right for
Retinitis Pigmentosa 11Retinal DegenerationRetinal Disease+2 more
PYC Therapeutics 16
Not applicableStudy completedNCT02800759
What this trial is testing

Effect of Cis-9-cetylmyristoleate in Sub-healthy Subjects Presenting With Knee Joint Pain

Who this might be right for
Knee Pain Intermittent
Seoul National University 28
Not applicableLooking for participantsNCT06785350
What this trial is testing

Minimum Effective Dose of Incisional Local Infiltration Betamethasone for the Prevention of Pain After Spinal Surgery

Who this might be right for
Pain ManagementSpine Surgery
Beijing Tiantan Hospital 535
Post-approval studies (Phase 4)UnknownNCT04196270
What this trial is testing

The Minimal Effective Volume (MEV90) of Ropivacaine 0.75% for Ultrasound-guided Transmuscular Quadratus Lumborum Block

Who this might be right for
Percutaneous Nephrolithotomy
Zealand University Hospital 40
Not applicableStudy completedNCT03568825
What this trial is testing

Response Surface Pathway Design With Two Interventional- and One Response Variable in Estimating Minimum Efficacy Dose

Who this might be right for
GERD
Meddoc 15
Not applicableStudy completedNCT02565303
What this trial is testing

Minimum Effective Dose of Ropivacaine for Spinal Anesthesia for Cesarean Delivery

Who this might be right for
Spinal Anesthesia
Shanghai 6th People's Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01620554
What this trial is testing

Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)

Who this might be right for
Obstructive Sleep ApnoeaExcessive Daytime Sleepiness
Bioprojet 110
Large-scale testing (Phase 3)Ended earlyNCT03733444
What this trial is testing

A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care

Who this might be right for
Idiopathic Pulmonary Fibrosis
Galapagos NV 781
Early research (Phase 1)Looking for participantsNCT07015684
What this trial is testing

131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

Who this might be right for
Sickling Disorder Due to Hemoglobin S
Columbia University 24
Load More Results